Quest Pharmatech Stock Net Income
QPT Stock | CAD 0.03 0.00 0.00% |
Quest PharmaTech fundamentals help investors to digest information that contributes to Quest PharmaTech's financial success or failures. It also enables traders to predict the movement of Quest Stock. The fundamental analysis module provides a way to measure Quest PharmaTech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Quest PharmaTech stock.
Quest |
Quest Net Income Analysis
Quest PharmaTech's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Quest PharmaTech Net Income | (7.33 M) |
Most of Quest PharmaTech's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Quest PharmaTech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition |
Based on the recorded statements, Quest PharmaTech reported net income of (7.33 Million). This is 102.15% lower than that of the Biotechnology sector and 110.47% lower than that of the Health Care industry. The net income for all Canada stocks is 101.28% higher than that of the company.
Quest Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Quest PharmaTech's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Quest PharmaTech could also be used in its relative valuation, which is a method of valuing Quest PharmaTech by comparing valuation metrics of similar companies.Quest PharmaTech is currently under evaluation in net income category among related companies.
Quest Fundamentals
Return On Equity | -0.29 | ||||
Return On Asset | -0.0094 | ||||
Current Valuation | 5.13 M | ||||
Shares Outstanding | 169.13 M | ||||
Shares Owned By Insiders | 17.12 % | ||||
Number Of Shares Shorted | 5 K | ||||
Price To Earning | (3.09) X | ||||
Price To Book | 0.06 X | ||||
Price To Sales | 515.97 X | ||||
EBITDA | (7.3 M) | ||||
Net Income | (7.33 M) | ||||
Cash And Equivalents | 4.41 M | ||||
Cash Per Share | 0.03 X | ||||
Total Debt | 1000 K | ||||
Current Ratio | 0.40 X | ||||
Book Value Per Share | 0.39 X | ||||
Cash Flow From Operations | (554.68 K) | ||||
Short Ratio | 0.08 X | ||||
Earnings Per Share | (0.12) X | ||||
Number Of Employees | 11 | ||||
Beta | 0.3 | ||||
Market Capitalization | 4.23 M | ||||
Total Asset | 84.36 M | ||||
Retained Earnings | 41.49 M | ||||
Working Capital | (484.9 K) | ||||
Z Score | 2.93 | ||||
Five Year Return | 32.58 % | ||||
Net Asset | 84.36 M |
About Quest PharmaTech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Quest PharmaTech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Quest PharmaTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Quest PharmaTech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Quest PharmaTech Inc., a biotechnology company, develops and commercializes antibody based immunotherapeutic products for cancer. The company also owns the Photodynamic therapy technology for oncology and dermatology applications and develops Mab AR 9.6 against truncated O-glycan on MUC16 for targeted cancer therapy applications. QUEST PHARMATECH operates under Biotechnology classification in Canada and is traded on TSX Venture Exchange.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Quest PharmaTech using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Quest PharmaTech Piotroski F Score and Quest PharmaTech Altman Z Score analysis. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Quest Stock analysis
When running Quest PharmaTech's price analysis, check to measure Quest PharmaTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest PharmaTech is operating at the current time. Most of Quest PharmaTech's value examination focuses on studying past and present price action to predict the probability of Quest PharmaTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest PharmaTech's price. Additionally, you may evaluate how the addition of Quest PharmaTech to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |